Mark Pollack to Risperidone
This is a "connection" page, showing publications Mark Pollack has written about Risperidone.
Connection Strength
0.283
-
An open-label trial of risperidone augmentation for refractory anxiety disorders. J Clin Psychiatry. 2006 Mar; 67(3):381-5.
Score: 0.283
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.